Presented on February 7, 2025.
Thank you to, Dyne Therapeutics for supporting our Communication Education Webinar Series at the Gold Sponsor Level!
Dyne Therapeutics presents updates on their DM1 program & new clinical data from their ongoing phase 1/2 ACHIEVE trial. Click here to learn more about Dyne Therapeutics.
Presenters include:
- Ashish Dugar, PhD, MBA, Chief Medical Affairs Officer
- Katherine Beaverson, MS, Vice President of Global Patient Advocacy
MDF Resources referenced in the Video:
- Toolkits & Publications
- MDF Support Groups
- Digital Academy
- Calendar of Events
- DM Drug Development Pipeline
- Myotonic Dystrophy Family Registry (MDFR)
- 2025 MDF Annual Conference
- Sign up for My Dispatch, our monthly e-newsletter
About Meet the Myotonic Dystrophy Drug Developers
Biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to find all our upcoming Meet the DM Drug Developers dates!